GlassScriptPhysician profile
Alan H Shapiro
NPI 1073713921
$36,873.32
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $3,229 · 2021: $6,278 · 2022: $5,187 · 2023: $6,640 · 2024: $3,570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,900 · Food and Beverage: $660 · Travel and Lodging: $641 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,900.00 |
| Food and Beverage | $659.99 |
| Travel and Lodging | $641.04 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $15,135.12 | 2022-2024 | Andexxa |
| E.R. Squibb & Sons, L.L.C. | $10,855.03 | 2019-2021 | |
| Pfizer INC. | $7,417.15 | 2019-2022 | |
| Portola Pharmaceuticals, LLC | $3,172.25 | 2020 | |
| Csl Behring | $122.95 | 2021-2024 | Kcentra |
| Btg International INC. | $59.41 | 2024 | |
| Purdue Pharma L.P. | $49.28 | 2024 | Nalmefene Hydrochloride |
| Kyowa Kirin, INC. | $35.15 | 2024 | Crysvita |
| Janssen Pharmaceuticals, INC | $26.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.